Allergan plans to expand its gastrointestinal research and development (R&D) pipeline and strengthen its position in non-alcoholic steatohepatitis through the acquisition of Tobira Therapeutics.

The company expects to complete the transaction by October 2016 at a cost of up to $1.6bn.

Cannabis Care Canada Inc has announced its acquirement of Mettrum Ltd from Mettrum Health Corporation for a purchase consideration of $5.3m.

Covington & Burling is acting as the legal advisor, while Centerview Partners and Citigroup Inc are acting as financial advisors to Allergan. SKadden, Arps, Slate, Meagher & Flom and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian are acting as legal advisors to Tobira Therapuetics.

Cannabis Care Canada Inc has announced its acquirement of Mettrum Ltd from Mettrum Health Corporation for a purchase consideration of $5.3m.

Pursuant to the acquisition, Mettrum will become a wholly owned subsidiary of CCC and will be renamed as Starseed Medicinal Inc.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The acquisition will allow Cannabis Care Canada to make cannabis treatment accessible to all of its members and their families.

Clinical Trials Arena Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Clinical Trials Arena Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now